Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Preventive Healthcare Services

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Marking Techniques for Target Lymph Nodes in Node-Positive Breast Cancer Treated With Neoadjuvant Therapy in the AXSANA/EUBREAST-03/AGO-B-053 Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Same author

Breast Cancer Specialist Training across Europe: A European Union of Medical Specialists Multidisciplinary Joint Committee Breast Care Survey.

Breast care (Basel, Switzerland)·2025

Same author

Axillary dissection for low-volume nodal involvement after neoadjuvant therapy in breast cancer: multicentre AXSANA cohort study.

The British journal of surgery·2025

Same author

Diagnostic performance of axillary ultrasound after neoadjuvant chemotherapy in initially node-positive breast cancer patients - Results from the prospective AXSANA registry trial.

European journal of cancer (Oxford, England : 1990)·2025

Same author

Lost axillary markers after neoadjuvant chemotherapy in breast cancer patients - data from the prospective international AXSANA (EUBREAST 3) cohort study (NCT04373655).

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2025

Same author

Radar reflectors for marking of target lymph nodes in initially node-positive patients receiving neoadjuvant chemotherapy for breast cancer-a subgroup analysis of the prospective AXSANA (EUBREAST-03) trial.

Breast cancer research and treatment·2025

Search research articles

Related Experiment Video

Updated: Dec 31, 2025

Author Spotlight: Demonstrating Systematic Endobronchial Ultrasound to New Endoscopists

Author Spotlight: Demonstrating Systematic Endobronchial Ultrasound to New Endoscopists

Published on: August 11, 2023

National Breast Screening Programs across Europe.

Florentia Peintinger^1,2

¹Institute of Pathology, Medical University of Graz, Graz, Austria.

Breast Care (Basel, Switzerland)

|January 15, 2020

Summary

European mammography screening programs have reduced breast cancer mortality by 25-30% in women aged 50-74. Digital mammography is widely adopted, but inequalities in screening implementation persist across the EU.

Keywords:

Breast cancer Mammography Screening program

More Related Videos

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

Related Experiment Videos

Last Updated: Dec 31, 2025

Author Spotlight: Demonstrating Systematic Endobronchial Ultrasound to New Endoscopists

Author Spotlight: Demonstrating Systematic Endobronchial Ultrasound to New Endoscopists

Published on: August 11, 2023

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

Area of Science:

Oncology
Public Health
Radiology

Background:

Mammography screening programs in Europe demonstrate significant breast cancer mortality reduction (25-30%) in women aged 50-74.
Early detection and multidisciplinary care improve outcomes, with population-based screening aiming for early diagnosis and reduced mortality.
Dedicated breast centers enhance patient care through specialized, coordinated approaches.

Purpose of the Study:

To review the implementation status of cancer screening programs across European countries.
To assess quality parameters and identify disparities in European cancer screening initiatives.
To evaluate the effectiveness and reach of current breast cancer screening strategies.

Main Methods:

A comprehensive review of existing cancer screening program data across European nations.
Analysis of quality parameters, including screening methods and age ranges.
Comparative assessment of implementation levels and identified inequalities.

Main Results:

Most European programs have adopted the recommended maximum age range for screening.
Digital mammography has largely replaced screen-film mammography in European screening programs.
Significant inequalities in the implementation of cancer screening have been observed within the European Union.

Conclusions:

Improvement in data quality is essential for effective cancer screening program evaluation.
Linking mortality registries with screening programs is crucial for accurate outcome assessment.
Addressing observed inequalities is necessary to ensure equitable access to breast cancer screening across Europe.